FOR US HEALTHCARE PROFESSIONALS ONLY
Celgene Corporation would like to introduce a mobile dosing app for ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound). Recommended doses and modifications for all three indications for ABRAXANE can be found within this mobile app. The dosing recommendations are based on the Prescribing Information for ABRAXANE. Also included is an overview of the trial design for each indication, including treatment arms, study dose, and patient population.
Please see full Prescribing Information, including Boxed WARNING for ABRAXANE at: http://www.abraxane.com/downloads/Abraxane_PrescribingInformation.pdf
An active link can be found in the Developer Website section below.
This App is not a medical device, but intended for use as an educational tool. Please help us by not talking directly about specific drugs or named medicines. Please do not use the app review area to report adverse events. Adverse Events should be reported to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
©2014 Celgene Corporation. 02/14. US-ABR130096a